GTC Biotherapeutics (fka GTCB)

[doofus_king]

Yup. GTCB's current market cap makes a decent deal unpossible for current shareholders. Management let the the stock price run down slowly over a period of months(negotiations are uncertain, it's certainly our goal, it's hard to predict, blah, blah, blah), diluted shareholders, didn't make a significant effort to cut back on expenses, and didn't even address cash burn. Basically took the company to the brink.

When they sell out they can crow about the huge premium they got for their beloved shareholders. 50%, 100% WOO-HOO! thanks for sticking with us! we got you a deal!

they keep their jobs, science, glory, and don't have to deal with stinking shareholders anymore.

Of course, that's the best case scenario at this point.